转运途中转移：黑色素瘤的迁移 - Suppr | 超能文献

In-transit metastases: the migration of melanoma.

作者信息

Pararajasingam Abirami, Goodwin Richard

机构信息

Department of Dermatology, St Woolos Hospital, Newport, UK.

出版信息

Br J Hosp Med (Lond). 2020 Sep 2;81(9):1. doi: 10.12968/hmed.2020.0202. Epub 2020 Sep 16.

DOI:10.12968/hmed.2020.0202

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

In-transit metastases: the migration of melanoma.转运途中转移：黑色素瘤的迁移

Br J Hosp Med (Lond). 2020 Sep 2;81(9):1. doi: 10.12968/hmed.2020.0202. Epub 2020 Sep 16.

2

[Treating metastatic melanoma: Risk management].[治疗转移性黑色素瘤：风险管理]

Ann Dermatol Venereol. 2017 Jan;144(1):3-5. doi: 10.1016/j.annder.2016.12.001. Epub 2017 Jan 4.

3

Resistance to PD-1 blockade in melanoma.黑色素瘤对PD-1阻断的耐药性。

Lancet Oncol. 2016 Sep;17(9):e376. doi: 10.1016/S1470-2045(16)30372-2. Epub 2016 Jul 22.

4

Diffuse Hepatic Infiltration by Metastatic Melanoma.转移性黑色素瘤所致的弥漫性肝浸润

Oncology (Williston Park). 2019 Jul 16;33(7):629386.

5

Third-line pembrolizumab-induced immune-related interstitial pneumonitis after ipilimumab and nivolumab failure.在伊匹木单抗和纳武单抗治疗失败后，三线使用帕博利珠单抗引发免疫相关间质性肺炎。

Eur J Dermatol. 2018 Feb 1;28(1):129-130. doi: 10.1684/ejd.2017.3192.

6

Vitiligo-like lesions located over In-transit metastases of malignant melanoma as a clinical marker of complete response to pembrolizumab.恶性黑色素瘤皮下转移灶处出现的白癜风样皮损作为帕博利珠单抗完全缓解的临床标志物。

Dermatol Online J. 2019 Dec 15;25(12):13030/qt8d3818j5.

7

Pembrolizumab (Keytruda°) and metastatic or inoperable melanoma.帕博利珠单抗（可瑞达°）与转移性或不可切除的黑色素瘤

Prescrire Int. 2017 May;26(182):118-119.

8

Unresectable Non-metastatic Primary Melanoma: Complete Remission Following Treatment with Anti-Programmed-cell-death-receptor 1.不可切除的非转移性原发性黑色素瘤：抗程序性细胞死亡受体1治疗后完全缓解

Acta Derm Venereol. 2019 Jan 1;99(1):107-108. doi: 10.2340/00015555-3028.

9

Persistence of superficial basal cell carcinoma during pembrolizumab treatment for metastatic melanoma.帕博利珠单抗治疗转移性黑色素瘤期间浅表基底细胞癌持续存在。

Eur J Dermatol. 2021 Feb 1;31(1):99-100. doi: 10.1684/ejd.2020.3958.

10

Deceleration in the rate of keratinocyte cancers and precancerous lesions during programmed death-1 inhibition therapy for advanced melanoma, with recrudescence on discontinuation.在晚期黑色素瘤程序性死亡-1抑制治疗期间，角质形成细胞癌和癌前病变的发生率下降，停药后复发。

Clin Exp Dermatol. 2022 Mar;47(3):582-584. doi: 10.1111/ced.14974. Epub 2021 Dec 28.

引用本文的文献

1

Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced Melanoma.基线[18F]氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描（[18F]FDG PET/CT）对晚期黑色素瘤患者全身治疗反应的预测价值

J Clin Med. 2021 Oct 27;10(21):4994. doi: 10.3390/jcm10214994.

2

Improved detection of in-transit metastases of malignant melanoma with BSREM reconstruction in digital [F]FDG PET/CT.BSREM 重建对数字化 [F]FDG PET/CT 中黑色素瘤转移的检出能力的改善。

Eur Radiol. 2021 Oct;31(10):8011-8020. doi: 10.1007/s00330-021-07852-7. Epub 2021 Mar 25.